Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Betahistine Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111433357B reveals high-ee enzymatic reduction for chiral alcohols, offering cost-effective and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN112481226B details solvent-tolerant ADH mutants for scalable production of chiral alcohols, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN111094557B details novel ADH mutants enabling cost-effective, high-ee biocatalytic synthesis of chiral biaryl alcohols for antihistamine drugs.